Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

U.S. fast food chains offering more healthy options for kids

Healthier sides and drinks were added to U.S. fast-food restaurant kids’ menus in the past decade, but healthy combinations are still rarely offered as the default option, researchers say.

Read More »

International aid saves 700 million lives but gains at risk: report

International aid financing and innovation has helped to save nearly 700 million lives in the past 25 years, but those gains could be lost if momentum and political will wane, global health experts said.

Read More »

China overtakes U.S. for healthy lifespan: WHO data

China has overtaken the United States in healthy life expectancy at birth for the first time, according to World Health Organization data.

Read More »

Can living near a gym make you slimmer?

People who live close to gyms, pools and playing fields weigh less and have smaller waistlines than their counterparts residing farther away from exercise facilities, a UK study suggests.

Read More »

Chocolate makers innovate to entice health-conscious consumers

The world’s largest chocolate makers are looking for ways to keep increasingly health-conscious consumers coming back for more.

Read More »

IBM: Your Computer Can Help Scientists Study Connection Between Body Bacteria and Autoimmune Diseases

The general public’s help is being enlisted in what is believed to be the largest study of the human microbiome – the bacteria that live in and on the human body – and are believed to affect health.

Read More »

Global health price tag could be $371 billion a year by 2030, WHO says

Meeting life-saving global health targets by 2030 could require investments by donors and national governments of up to $58 per person per year, or $371 billion annually, the World Health Organization (WHO) said.

Read More »

BioPharm Executive: Let’s Get Rid of Clinical Trials

We’re living in volatile times. If I were to put a positive spin on that, I’d say that we’re living in times where a lot of accepted ways of doing things are being questioned. And those questions can be healthy. Take the FDA, for example. Pretty much every new president pays at least some lip service to the idea of speeding up drug approvals, cutting red tape, and helping the life sciences become more innovative. But President Trump apparently seriously considered appointing Jim O’Neill or Balaji Srinivasan as FDA Commissioner. Both O’Neill and Srinivasan are associates of Silicon Valley libertarian/iconoclast Peter Thiel, and have argued that drugs should be approved on the basis of safety alone, with the “market” deciding on whether they’re effective. (Healthcare is hardly a market in the normal sense of the term, hence the quotes.) O’Neill in particular would have done away with most clinical trials altogether.

Read More »

Sanofi Delivers Robust Q1 2017 Financial Results

Sanofi’s net sales for first-quarter 2017 amounted to €8.65 billion, up 11.1% on a reported basis and 8.6% at CER, reflecting the acquisition of Boehringer Ingelheim’s CHC business and full consolidation of Sanofi’s European vaccine operations. At constant structure and CER, net sales for the 2017 first quarter were up 3.5% year over year.

Read More »

On your bike: Cycling to work linked with large health benefits

People who cycle to work have a substantially lower risk of developing cancer or heart disease or dying prematurely, and governments should do all they can to encourage more active commuting, scientists said.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

December 2018 Focus: Healthcare Agency Roundtable, Mobile Marketing, and more!

Subscribe

Ad Right Bottom